{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T23:28:56Z","timestamp":1785540536608,"version":"3.56.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T00:00:00Z","timestamp":1764374400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T00:00:00Z","timestamp":1764374400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the Science and Technology Development Fund of Shanghai Pudong New Area","award":["PKJ2021\u2013Y38"],"award-info":[{"award-number":["PKJ2021\u2013Y38"]}]},{"name":"the Medical Discipline Construction Program of Shanghai Pudong New Area Health Commissio","award":["PWGw2025-01"],"award-info":[{"award-number":["PWGw2025-01"]}]},{"name":"the Discipline Construction Promoting Project of Shanghai Pudong Hospital","award":["Zdzk2020-10"],"award-info":[{"award-number":["Zdzk2020-10"]}]},{"name":"the Discipline Construction Promoting Project of Shanghai Pudong Hospital","award":["Tszb2023-01"],"award-info":[{"award-number":["Tszb2023-01"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1007\/s10620-025-09576-w","type":"journal-article","created":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T07:36:50Z","timestamp":1764401810000},"page":"1805-1820","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Helicobacter pylori Lipopolysaccharide Upregulates MDM2 via the TLR4\/MAPK\/AP-1 Pathway to Promote Gastric Cancer Progression"],"prefix":"10.1007","volume":"71","author":[{"given":"Yuqin","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baiqing","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuyu","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wujun","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenqing","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dejun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,29]]},"reference":[{"key":"9576_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71:209\u2013249.","journal-title":"CA Cancer J Clin."},{"key":"9576_CR2","doi-asserted-by":"crossref","unstructured":"Reeves EP, Ali T, Leonard Pet al. (2008) Helicobacter pylori lipopolysaccharide interacts with TFF1 in a pH-dependent manner. Gastroenterology. 135:2043\u20132054, 2054 e2041\u20132042.","DOI":"10.1053\/j.gastro.2008.08.049"},{"key":"9576_CR3","doi-asserted-by":"crossref","unstructured":"Ito N, Tsujimoto H, Ueno H, Xie Q, Shinomiya N. (2020) Helicobacter pylori-Mediated Immunity and Signaling Transduction in Gastric Cancer. J Clin Med. 9.","DOI":"10.3390\/jcm9113699"},{"key":"9576_CR4","doi-asserted-by":"publisher","first-page":"4777","DOI":"10.1021\/acs.molpharmaceut.8b00691","volume":"15","author":"MA Shetab Boushehri","year":"2018","unstructured":"Shetab Boushehri MA, Lamprecht A. TLR4-Based Immunotherapeutics in Cancer: A Review of the Achievements and Shortcomings. Mol Pharm. 2018;15:4777\u20134800.","journal-title":"Mol Pharm."},{"key":"9576_CR5","doi-asserted-by":"publisher","first-page":"e794","DOI":"10.1038\/cddis.2013.334","volume":"4","author":"X Yuan","year":"2013","unstructured":"Yuan X, Zhou Y, Wang W et al. Activation of TLR4 signaling promotes gastric cancer progression by inducing mitochondrial ROS production. Cell Death Dis. 2013;4:e794.","journal-title":"Cell Death Dis."},{"key":"9576_CR6","doi-asserted-by":"publisher","first-page":"4365","DOI":"10.1038\/onc.2013.410","volume":"33","author":"R Fahraeus","year":"2014","unstructured":"Fahraeus R, Olivares-Illana V. MDM2\u2019s social network. Oncogene. 2014;33:4365\u20134376.","journal-title":"Oncogene."},{"key":"9576_CR7","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.7150\/ijms.47360","volume":"18","author":"X Jiang","year":"2021","unstructured":"Jiang X, Yuan J, Dou Y, Zeng D, Xiao S. Lipopolysaccharide Affects the Proliferation and Glucose Metabolism of Cervical Cancer Cells Through the FRA1\/MDM2\/p53 Pathway. Int J Med Sci. 2021;18:1030\u20131038.","journal-title":"Int J Med Sci."},{"key":"9576_CR8","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s13058-023-01657-w","volume":"25","author":"M Qi","year":"2023","unstructured":"Qi M, Yi X, Yue B, Huang M, Zhou S, Xiong J. S100A6 inhibits MDM2 to suppress breast cancer growth and enhance sensitivity to chemotherapy. Breast Cancer Res. 2023;25:55.","journal-title":"Breast Cancer Res."},{"key":"9576_CR9","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1038\/bjc.2017.265","volume":"117","author":"Y Chen","year":"2017","unstructured":"Chen Y, Wang DD, Wu YP et al. MDM2 promotes epithelial-mesenchymal transition and metastasis of ovarian cancer SKOV3 cells. Br J Cancer. 2017;117:1192\u20131201.","journal-title":"Br J Cancer."},{"key":"9576_CR10","doi-asserted-by":"publisher","first-page":"7161","DOI":"10.1158\/0008-5472.CAN-14-1446","volume":"74","author":"X Meng","year":"2014","unstructured":"Meng X, Franklin DA, Dong J, Zhang Y. MDM2-p53 pathway in hepatocellular carcinoma. Cancer Res. 2014;74:7161\u20137167.","journal-title":"Cancer Res."},{"key":"9576_CR11","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1021\/jm501092z","volume":"58","author":"Y Zhao","year":"2015","unstructured":"Zhao Y, Aguilar A, Bernard D, Wang S. Small-molecule inhibitors of the MDM2-p53 protein-protein interaction (MDM2 Inhibitors) in clinical trials for cancer treatment. J Med Chem. 2015;58:1038\u20131052.","journal-title":"J Med Chem."},{"key":"9576_CR12","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1186\/s40425-019-0750-6","volume":"7","author":"DD Fang","year":"2019","unstructured":"Fang DD, Tang Q, Kong Y et al. MDM2 inhibitor APG-115 synergizes with PD-1 blockade through enhancing antitumor immunity in the tumor microenvironment. J Immunother Cancer. 2019;7:327.","journal-title":"J Immunother Cancer."},{"key":"9576_CR13","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.canlet.2016.03.018","volume":"375","author":"TY Lin","year":"2016","unstructured":"Lin TY, Hsu HY. Ling Zhi-8 reduces lung cancer mobility and metastasis through disruption of focal adhesion and induction of MDM2-mediated Slug degradation. Cancer Lett. 2016;375:340\u2013348.","journal-title":"Cancer Lett."},{"key":"9576_CR14","doi-asserted-by":"publisher","first-page":"1138200","DOI":"10.1080\/2162402X.2016.1138200","volume":"5","author":"P Li","year":"2016","unstructured":"Li P, Shi JX, Dai LP et al. Serum anti-MDM2 and anti-c-Myc autoantibodies as biomarkers in the early detection of lung cancer. Oncoimmunology. 2016;5:1138200.","journal-title":"Oncoimmunology."},{"key":"9576_CR15","doi-asserted-by":"publisher","first-page":"1010326","DOI":"10.1371\/journal.ppat.1010326","volume":"18","author":"B Schmidinger","year":"2022","unstructured":"Schmidinger B, Petri K, Lettl C et al. Helicobacter pylori binds human Annexins via Lipopolysaccharide to interfere with Toll-like Receptor 4 signaling. PLoS Pathog. 2022;18:1010326.","journal-title":"PLoS Pathog."},{"key":"9576_CR16","doi-asserted-by":"crossref","unstructured":"Zhou XY, Fang DL, Liu HHet al. (2022) PMN-MDSCs accumulation induced by CXCL1 promotes CD8T cells exhaustion in gastric cancer. Cancer Letters. 532.","DOI":"10.1016\/j.canlet.2022.215598"},{"key":"9576_CR17","first-page":"867","volume":"89","author":"EK Kim","year":"2015","unstructured":"Kim EK, Choi EJ. Compromised MAPK signaling in human diseases: an update Arch Toxicol. 2015;89:867\u2013882.","journal-title":"Compromised MAPK signaling in human diseases: an update Arch Toxicol."},{"key":"9576_CR18","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1126\/science.1092472","volume":"303","author":"LT Vassilev","year":"2004","unstructured":"Vassilev LT, Vu BT, Graves B et al. In vivo activation of the p53 pathway by small-molecule antagonists of MDM2. Science. 2004;303:844\u2013848.","journal-title":"Science."},{"key":"9576_CR19","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s11658-020-00233-w","volume":"25","author":"R Li","year":"2020","unstructured":"Li R, Zatloukalova P, Muller P et al. The MDM2 ligand Nutlin-3 differentially alters expression of the immune blockade receptors PD-L1 and CD276. Cell Mol Biol Lett. 2020;25:41.","journal-title":"Cell Mol Biol Lett."},{"key":"9576_CR20","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1111\/j.1349-7006.2010.01821.x","volume":"102","author":"S Endo","year":"2011","unstructured":"Endo S, Yamato K, Hirai S et al. Potent in vitro and in vivo antitumor effects of MDM2 inhibitor nutlin-3 in gastric cancer cells. Cancer Sci. 2011;102:605\u2013613.","journal-title":"Cancer Sci."},{"key":"9576_CR21","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/ni.2885","volume":"15","author":"Q Zou","year":"2014","unstructured":"Zou Q, Jin J, Hu H et al. USP15 stabilizes MDM2 to mediate cancer-cell survival and inhibit antitumor T cell responses. Nat Immunol. 2014;15:562\u2013570.","journal-title":"Nat Immunol."},{"key":"9576_CR22","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1038\/s41590-021-00888-3","volume":"22","author":"J Zhou","year":"2021","unstructured":"Zhou J, Kryczek I, Li S et al. The ubiquitin ligase MDM2 sustains STAT5 stability to control T cell-mediated antitumor immunity. Nat Immunol. 2021;22:460\u2013470.","journal-title":"Nat Immunol."},{"key":"9576_CR23","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1146\/annurev.immunol.25.022106.141623","volume":"30","author":"SZ Josefowicz","year":"2012","unstructured":"Josefowicz SZ, Lu LF, Rudensky AY. Regulatory T cells: mechanisms of differentiation and function. Annu Rev Immunol. 2012;30:531\u2013564.","journal-title":"Annu Rev Immunol."},{"key":"9576_CR24","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1111\/apt.12814","volume":"40","author":"KM Fock","year":"2014","unstructured":"Fock KM. Review article: the epidemiology and prevention of gastric cancer. Aliment Pharmacol Ther. 2014;40:250\u2013260.","journal-title":"Aliment Pharmacol Ther."},{"key":"9576_CR25","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1186\/s12935-019-0937-4","volume":"19","author":"H Hou","year":"2019","unstructured":"Hou H, Sun D, Zhang X. The role of MDM2 amplification and overexpression in therapeutic resistance of malignant tumors. Cancer Cell Int. 2019;19:216.","journal-title":"Cancer Cell Int."},{"key":"9576_CR26","doi-asserted-by":"publisher","first-page":"196","DOI":"10.3164\/jcbn.08-254","volume":"44","author":"N Nakajima","year":"2009","unstructured":"Nakajima N, Ito Y, Yokoyama K et al. The Expression of Murine Double Minute 2 (MDM2) on Helicobacter pylori-Infected Intestinal Metaplasia and Gastric Cancer. J Clin Biochem Nutr. 2009;44:196\u2013202.","journal-title":"J Clin Biochem Nutr."},{"key":"9576_CR27","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.clinre.2011.11.009","volume":"36","author":"Z Yang","year":"2012","unstructured":"Yang Z, Shu X, Chen L, Chen J, Xie Y, Lu NH. Expression of p53-MDM2 feedback loop related proteins in different gastric pathologies in relation to Helicobacter pylori infection: implications in gastric carcinogenesis. Clin Res Hepatol Gastroenterol. 2012;36:235\u2013243.","journal-title":"Clin Res Hepatol Gastroenterol."},{"key":"9576_CR28","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.molmed.2012.07.006","volume":"18","author":"R Barros","year":"2012","unstructured":"Barros R, Freund JN, David L. Almeida R. Gastric intestinal metaplasia revisited: function and regulation of CDX2. Trends Mol Med. 2012;18:555\u2013563.","journal-title":"Trends Mol Med."},{"key":"9576_CR29","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1111\/j.1440-1746.2005.03880.x","volume":"20","author":"M Kodama","year":"2005","unstructured":"Kodama M, Fujioka T, Murakami K et al. Eradication of Helicobacter pylori reduced the immunohistochemical detection of p53 and MDM2 in gastric mucosa. J Gastroenterol Hepatol. 2005;20:941\u2013946.","journal-title":"J Gastroenterol Hepatol."},{"key":"9576_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.868225","volume":"13","author":"D Sijmons","year":"2022","unstructured":"Sijmons D, Guy AJ, Walduck AK, Ramsland PA. Helicobacter pylori and the Role of Lipopolysaccharide Variation in Innate Immune Evasion. Front Immunol. 2022;13:868225.","journal-title":"Front Immunol."},{"key":"9576_CR31","doi-asserted-by":"crossref","unstructured":"Sasaran MO, Melit LE, Dobru ED. (2021) MicroRNA Modulation of Host Immune Response and Inflammation Triggered by Helicobacter pylori. Int J Mol Sci. 22.","DOI":"10.3390\/ijms22031406"},{"key":"9576_CR32","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1016\/S0264-410X(97)00102-3","volume":"15","author":"T Ogawa","year":"1997","unstructured":"Ogawa T, Suda Y, Kashihara W et al. Immunobiological activities of chemically defined lipid A from Helicobacter pylori LPS in comparison with Porphyromonas gingivalis lipid A and Escherichia coli-type synthetic lipid A (compound 506). Vaccine. 1997;15:1598\u20131605.","journal-title":"Vaccine."},{"key":"9576_CR33","doi-asserted-by":"publisher","first-page":"2909","DOI":"10.1158\/1078-0432.CCR-07-4467","volume":"14","author":"K Chochi","year":"2008","unstructured":"Chochi K, Ichikura T, Kinoshita M et al. Helicobacter pylori augments growth of gastric cancers via the lipopolysaccharide-toll-like receptor 4 pathway whereas its lipopolysaccharide attenuates antitumor activities of human mononuclear cells. Clin Cancer Res. 2008;14:2909\u20132917.","journal-title":"Clin Cancer Res."},{"key":"9576_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.carbpol.2020.117350","volume":"253","author":"LM Silva","year":"2021","unstructured":"Silva LM, Correia VG, Moreira ASP et al. Helicobacter pylori lipopolysaccharide structural domains and their recognition by immune proteins revealed with carbohydrate microarrays. Carbohydr Polym. 2021;253:117350.","journal-title":"Carbohydr Polym."},{"key":"9576_CR35","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1007\/s00428-023-03674-8","volume":"483","author":"S Abdullazade","year":"2023","unstructured":"Abdullazade S, Behrens HM, Kruger S, Haag J, Rocken C. MDM2 amplification is rare in gastric cancer. Virchows Arch. 2023;483:795\u2013807.","journal-title":"Virchows Arch."},{"key":"9576_CR36","doi-asserted-by":"publisher","first-page":"E131","DOI":"10.1038\/ncb0502-e131","volume":"4","author":"E Shaulian","year":"2002","unstructured":"Shaulian E, Karin M. AP-1 as a regulator of cell life and death. Nat Cell Biol. 2002;4:E131-136.","journal-title":"Nat Cell Biol."},{"key":"9576_CR37","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1002\/jcp.21041","volume":"212","author":"R Kajanne","year":"2007","unstructured":"Kajanne R, Miettinen P, Mehlem A et al. EGF-R regulates MMP function in fibroblasts through MAPK and AP-1 pathways. J Cell Physiol. 2007;212:489\u2013497.","journal-title":"J Cell Physiol."},{"key":"9576_CR38","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1101\/gad.1941710","volume":"24","author":"JJ Manfredi","year":"2010","unstructured":"Manfredi JJ. The Mdm2-p53 relationship evolves: Mdm2 swings both ways as an oncogene and a tumor suppressor. Genes Dev. 2010;24:1580\u20131589.","journal-title":"Genes Dev."},{"key":"9576_CR39","doi-asserted-by":"publisher","first-page":"4862","DOI":"10.1128\/MCB.01584-07","volume":"28","author":"A Bouska","year":"2008","unstructured":"Bouska A, Lushnikova T, Plaza S, Eischen CM. Mdm2 promotes genetic instability and transformation independent of p53. Mol Cell Biol. 2008;28:4862\u20134874.","journal-title":"Mol Cell Biol."},{"key":"9576_CR40","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1158\/0008-5472.CAN-08-3732","volume":"69","author":"A Bouska","year":"2009","unstructured":"Bouska A, Eischen CM. Mdm2 affects genome stability independent of p53. Cancer Res. 2009;69:1697\u20131701.","journal-title":"Cancer Res."},{"key":"9576_CR41","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/cr.2016.151","volume":"27","author":"A Tanaka","year":"2017","unstructured":"Tanaka A, Sakaguchi S. Regulatory T cells in cancer immunotherapy. Cell Res. 2017;27:109\u2013118.","journal-title":"Cell Res."},{"key":"9576_CR42","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.clim.2006.07.002","volume":"121","author":"K Enarsson","year":"2006","unstructured":"Enarsson K, Lundgren A, Kindlund B et al. Function and recruitment of mucosal regulatory T cells in human chronic Helicobacter pylori infection and gastric adenocarcinoma. Clin Immunol. 2006;121:358\u2013368.","journal-title":"Clin Immunol."},{"key":"9576_CR43","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.clim.2009.10.005","volume":"134","author":"XL Yuan","year":"2010","unstructured":"Yuan XL, Chen L, Li MX et al. Elevated expression of Foxp3 in tumor-infiltrating Treg cells suppresses T-cell proliferation and contributes to gastric cancer progression in a COX-2-dependent manner. Clin Immunol. 2010;134:277\u2013288.","journal-title":"Clin Immunol."},{"key":"9576_CR44","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1007\/s10120-015-0591-z","volume":"20","author":"B Kindlund","year":"2017","unstructured":"Kindlund B, Sjoling A, Yakkala C et al. CD4(+) regulatory T cells in gastric cancer mucosa are proliferating and express high levels of IL-10 but little TGF-beta. Gastric Cancer. 2017;20:116\u2013125.","journal-title":"Gastric Cancer."},{"key":"9576_CR45","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3748\/wjg.v18.i1.34","volume":"18","author":"HH Cheng","year":"2012","unstructured":"Cheng HH, Tseng GY, Yang HB, Wang HJ, Lin HJ, Wang WC. Increased numbers of Foxp3-positive regulatory T cells in gastritis, peptic ulcer and gastric adenocarcinoma. World J Gastroenterol. 2012;18:34\u201343.","journal-title":"World J Gastroenterol."},{"key":"9576_CR46","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1053\/j.gastro.2006.05.001","volume":"131","author":"R Rad","year":"2006","unstructured":"Rad R, Brenner L, Bauer S et al. CD25+\/Foxp3+ T cells regulate gastric inflammation and Helicobacter pylori colonization in vivo. Gastroenterology. 2006;131:525\u2013537.","journal-title":"Gastroenterology."},{"key":"9576_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2020.06.016","volume":"53","author":"S Kumagai","year":"2020","unstructured":"Kumagai S, Togashi Y, Sakai C et al. An oncogenic alteration creates a microenvironment that promotes tumor progression by conferring a metabolic advantage to regulatory T Cells. Immunity. 2020;53:e188.","journal-title":"Immunity."}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-025-09576-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-025-09576-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-025-09576-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T06:03:08Z","timestamp":1779688988000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-025-09576-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,29]]},"references-count":47,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["9576"],"URL":"https:\/\/doi.org\/10.1007\/s10620-025-09576-w","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,29]]},"assertion":[{"value":"14 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Shanghai Pudong Hospital (Shanghai, China) with the approval number: QKW-03. All patients provided informed consent for the publication of their case details.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}